CLAVAMOXY 625 DUO: Optimal Synergy for Advanced Infection Control.

CLAVAMOXY 625 DUO

Amoxicillin (500mg) and Clavulanic Acid (125mg)

CLAVAMOXY 625 DUO, a flagship product from Steris Pharma, embodies a powerful combination of Amoxicillin (500mg) and Clavulanic Acid (125mg). This dynamic duo works synergistically to treat a wide array of bacterial infections more effectively than amoxicillin alone. The addition of clavulanic acid, a beta-lactamase inhibitor, protects amoxicillin from degradation by beta-lactamase enzymes, enhancing its spectrum of activity.

Understanding the Components

• Amoxicillin: A penicillin-type antibiotic, amoxicillin is effective against a broad range of gram-positive and gram-negative bacteria.
• Clavulanic Acid: This component inhibits beta-lactamases, enzymes produced by bacteria that can inactivate many penicillin-type antibiotics. By blocking these enzymes, clavulanic acid ensures that amoxicillin remains potent and effective.

Therapeutic Applications of CLAVAMOXY 625 DUO

• Respiratory Tract Infections: Highly effective against conditions like sinusitis, pneumonia, and bronchitis.
• Urinary Tract Infections: Combats the pathogens causing UTIs, including those resistant to other antibiotics.
• Skin and Soft Tissue Infections: Treats infections such as abscesses, cellulitis, and wound infections.
• Dental Infections: Prevents and treats infections following dental procedures and tooth extractions.

Dosage and Administration

CLAVAMOXY 625 DUO is typically administered every 12 hours (twice a day), with doses adjusted based on the severity of the infection and the patient's medical history. It can be taken with or without food, but taking it with meals can help reduce gastrointestinal side effects.

Advantages of CLAVAMOXY 625 DUO

• Enhanced Efficacy: The combination of amoxicillin with clavulanic acid allows it to fight bacteria that would normally be resistant to amoxicillin alone.
• Broad-Spectrum Activity: Effective against a wide range of bacteria, making it a versatile choice for various infections.
• Good Tolerability: Generally well tolerated by patients, with a low incidence of side effects.

Safety and Precautions

While CLAVAMOXY 625 DUO is generally safe, it may cause some side effects such as diarrhea, nausea, and, in rare cases, allergic reactions. Patients with a history of penicillin or cephalosporin allergies should discuss alternative treatments with their healthcare provider.

Conclusion

CLAVAMOXY 625 DUO stands as a testament to Steris Pharma’s commitment to providing robust healthcare solutions. It offers a potent, broad-spectrum antibiotic option that is pivotal in the management of various bacterial infections. Whether it's a stubborn respiratory infection or a severe skin condition, CLAVAMOXY 625 DUO provides a reliable, effective treatment pathway, ensuring swift recovery and optimal patient outcomes. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW